Drug Feeder
The dual rotating system with vibration and reverse rotation controls in the drug feeder addresses drug retention and congestion issues, ensuring accurate empty detection and efficient discharge of remaining drugs.
Patent Information
- Application Number
- JP2021035522
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-03-05
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2041-03-05
AI Technical Summary
Existing drug feeders face issues with drug retention due to adhesion and static forces, leading to incorrect empty detection and congestion during sequential discharge, especially when only a small amount of drugs remain.
The drug feeder employs a dual rotating system with a tilting rotating body and an annular rotating body, utilizing vibration and reverse rotation controls to prevent drug retention, along with a regulating mechanism that adjusts the drug transport path width to alleviate congestion.
The solution effectively reduces drug retention and congestion, ensuring accurate detection of empty status and efficient discharge of remaining drugs without damage, even when only a small amount remains.
Smart Images

Figure 0007584137000001 
Figure 0007584137000002 
Figure 0007584137000003
Abstract
Description
[Technical field]
[0001] This invention relates to a drug feeder that automatically supplies granular solid medicines such as tablets and ampoules in order to automate the dispensing process in hospitals, pharmacies, etc. More specifically, this invention relates to a drug feeder that randomly stores a large number of medicines of the same shape and aligns them with a rotating body to sequentially feed and discharge the medicines one by one. More specifically, this invention relates to an enhanced judgment function in the drug discharge operation control that judges whether the stored medicine cannot be discharged when the timeout for discharge has expired (timeout, timeover). [Background technology]
[0002] A drug feeder has been put into practical use which comprises an outer annular rotor rotatable around a vertical line, an inclined rotor mounted inside the annular rotor rotatable around an inclined line inclined from the vertical line and blocking the hollow of the annular rotor, a regulating mechanism which aligns solid drugs carried from above the inclined rotor to the upper peripheral edge of the annular rotor by the rotation of the inclined rotor as the annular rotor rotates, a control unit which controls the rotation of the annular rotor and the inclined rotor, and a drug drop detection means which detects drugs carried to a drop discharge port by the annular rotor and dropped, wherein the regulating member regulates the width of a drug transport path above the upper peripheral edge of the annular rotor (see Patent Documents 1 to 3). In such a drug feeder, there is no need to provide a fixed flow straightening guide within the rotor, and the range of compatibility with drugs of various shapes and sizes is expanded.
[0003] Furthermore (see Patent Documents 2 to 4), by forming grooves or engravings on the upper surface of the upper peripheral portion of the annular rotor to improve drug transport capacity, by giving the regulating mechanism for aligning drugs a height regulating function in addition to a width regulating function for the drugs to be aligned, and by providing a sorting mechanism that suspends the action part above the drug transport path to diversify the means for dissolving drugs, it has become possible to effortlessly align solid drugs in a row on the drug transport path at the upper peripheral portion of the annular rotor, from hard and durable drugs to brittle drugs, and even from plate-shaped drugs that are difficult to roll to spherical or spindle-shaped drugs that roll easily.
[0004] Furthermore, (see Patent Documents 2 to 4), various attempts have been made to control the rotation performed by the controller (control unit), such as starting with a slow rotation speed and then switching to a high rotation speed, estimating the drug size based on the drug detection time length measured when the first falling drug is detected and adjusting the rotation speed, slowing down the rotation speed when the remaining number calculated from the specified total number to be discharged and the counted number of drugs already discharged becomes small, and performing reverse rotation (rearward rotation) to prevent undesirable excessive dropping after drug discharge is completed. However, due to the cost of adding components and constraints on placement, detection of when all drugs in the drug feeder have been discharged and the drug feeder is empty is left to a timeout when the drug detection waiting time by the drug fall detection means exceeds a predetermined time. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2018-108277 A [Patent Document 2] Patent No. 6736074 [Patent Document 3] Patent No. 6736075 [Patent Document 4] Patent Application No. 2020-012424 (Application) [Patent Document 5] Patent Application No. 2020-214571 (Application) Summary of the Invention [Problem to be solved by the invention]
[0006] However, there is a complaint about such a control method that determines the completion of drug feeder discharge by the expiration of the time when detecting the drug. If a drug jam occurs at the regulating mechanism during sequential drug discharge, even though it is rare, and the sequential drug discharge function is significantly impaired, the detection of dropped drugs by the drug drop detection means will cease, and the resulting undesired expiration of the drug discharge detection may lead to a false determination that all drugs in the feeder have been discharged and the drug feeder is empty. Regarding this (see Patent Document 5), a measure has been taken to gradually widen the width of the drug transport path to alleviate or eliminate the jam before the time expires.
[0007] However, unlike the situation when a drug jam occurs, in a situation where only one drug particle remains on a rotating body such as an inclined rotor or annular rotor, or even if multiple drugs remain, they are few in number and scattered enough that they do not affect each other, it cannot be said that there is no possibility that the drug will not continue to remain on the inclined rotor, or that even if the drug is on the annular rotor, it will continue to remain on the discharge guide or the transport surface guide at the end of the disc, due to interactions between the surfaces of objects such as attractive forces due to static electricity, adhesive forces due to moisture, and even snagging due to minute unevenness on the surface, even if the effects are slight.
[0008] Furthermore, unlike a cassette-detachable drug feeder that assigns a dedicated container cassette for each drug, the drug feeder of the present application, which incorporates a double inner and outer rotor, is not intended to have the inclined rotor or annular rotor equivalent to the container section detached during normal use, and is shared for various types of drugs, so it is necessary to accurately avoid erroneously determining that the drug feeder is empty because the contained drug has run out, even though there is still drug remaining. Therefore, the technical challenge is to reduce or eliminate the causes of drug retention so that the remaining drug is discharged before the drug discharge detection timeout expires, even when only a small amount of remaining drug remains. [Means for solving the problem]
[0009] The drug feeder of the present invention (Solution 1) has been invented to solve such problems, and comprises an outer annular rotor rotatable around a vertical line, an inclined rotor mounted inside the annular rotor rotatable around an inclined line inclined from the vertical line and sealing the hollow of the annular rotor, a regulating mechanism for aligning solid drugs carried from above the inclined rotor to the upper peripheral edge of the annular rotor by the rotation of the inclined rotor as the annular rotor rotates, a control unit which controls the rotation of the annular rotor and the rotation of the inclined rotor, and drug drop detection means which detects drugs carried to a drop discharge port by the annular rotor and dropped, and the control unit is configured to wait for drug detection by the drug drop detection means while controlling the rotation, and determine that the contained drugs have run out when a predetermined time has elapsed The inclined rotating body can rotate both forward and backward around the inclined line, The control unit, prior to the timeout By controlling the inclined rotor to alternately rotate in a small forward direction in response to vibration and in a reverse direction smaller than the forward direction, The present invention is characterized in that a vibration rotation control is performed in which the inclined rotor is rotated while being vibrated.
[0010] Furthermore, the drug feeder of the present invention (Solution Means 2) is the drug feeder of Solution Means 1 described above, characterized in that the vibration rotation control is performed by repeating a small forward rotation (rotation in the advancing direction) corresponding to the vibration and an even smaller reverse rotation (rotation in the retreating direction).
[0011] Furthermore, the drug feeder of the present invention (Solution 3) is a drug feeder of Solutions 1 and 2 above, characterized in that the control unit is configured to perform swing-out reversal control for rotating the inclined rotor in the reverse direction at high speed after executing the vibration rotation control.
[0012] Furthermore, the drug feeder of the present invention (Solution Means 4) is the drug feeder of Solution Means 3 described above, characterized in that the control unit is configured to perform forward swing control for rotating the inclined rotor in the forward direction at high speed after executing the reverse swing control.
[0013] Furthermore, the drug feeder of the present invention (Solution 5) is a drug feeder according to Solutions 1 to 4 above, characterized in that the regulating mechanism regulates the lateral width of the drug transport path above the upper peripheral edge of the annular rotor, and the amount of regulating the lateral width is increased or decreased according to the control of the control unit, and the control unit controls the regulating mechanism to increase the lateral width when the drug detection interval by the drug drop detection means reaches a set value of a congestion interval which is larger than a normal interval, prior to executing the vibration rotation control.
[0014] Furthermore, the drug feeder of the present invention (Solution 6) is the drug feeder of Solution 5 above, characterized in that when the drug fall detection means detects drug fall after the control unit controls the regulating mechanism to expand the width, the control unit accordingly controls the regulating mechanism to return the width to before it was expanded.
[0015] Furthermore, the drug feeder of the present invention (Solution 7) is the drug feeder of the above-mentioned Solutions 5 and 6, characterized in that the control unit is adapted to increase the lateral width in a stepwise manner. Effect of the Invention
[0016] In such a drug feeder of the present invention (Solution 1), when the inclined rotor is rotated to transfer the drug from the inclined rotor to the annular rotor, vibration is superimposed on the rotation when the time runs out, so that even when the amount of drug on the inclined rotor is reduced and the action of adhesive force or the like that tries to keep the drug on the inclined rotor becomes relatively effective, the action is suppressed or eliminated by the vibration, so that undesired drug residue on the inclined rotor can be avoided. Also, the vibration superimposed on the rotation of the inclined rotor includes a vibration component in the vertical direction, and this vibration is transmitted to the annular rotor and further to the support member, discharge guide, etc., so that undesired drug residue on the annular rotor, etc. can also be avoided. Therefore, according to the present invention, even when the amount of remaining medicine is small, it is possible to reduce or eliminate the cause of medicine retention so that the medicine is discharged before the medicine discharge detection time expires.
[0017] Furthermore, in the drug feeder of the present invention (Solution 2), vibration rotation control is performed by repeating small forward rotations, i.e., rotation in the forward direction corresponding to the vibration, and smaller reverse rotations, i.e., rotation in the backward direction, so that by selecting a rotation drive motor for the inclined rotor that can rotate in both directions, this can be easily realized without adding an additional vibration motor, etc.
[0018] Furthermore, in the drug feeder of the present invention (Solutions 3 and 4), by immediately adding high-speed reverse rotation (fast backward rotation) or high-speed forward rotation (fast forward rotation) of the inclined rotor after the adhesive force of the drug has been suppressed or eliminated by the vibration rotation control, the remaining drug on the inclined rotor is quickly transferred onto the annular rotor before the undesirable adhesive force, etc., is restored. Therefore, it is possible to accurately avoid residual medicine without wasting the effect of reducing or eliminating the causes of medicine retention by the preceding vibration and rotation control.
[0019] Furthermore, in the drug feeder of the present invention (solutions 5 and 6), the drug detection interval for drugs carried to the drop discharge port by the annular rotor and dropped is a known normal time interval (time interval under normal conditions) or a time close to that under normal drug discharge operation, but when it reaches a longer congestion interval (time interval under congestion), it is determined that there is a high possibility that an undesirable drug congestion state has occurred in the drug transport path at the upper peripheral edge of the annular rotor, and the regulating mechanism is activated to widen the width of the drug transport path, thereby temporarily relaxing the restriction on the drug passing past the regulating mechanism.
[0020] In this way, when a drug jam occurs in which a large number of drugs are stuck at the regulating member and lined up in the transport direction, this is detected as a discharge delay and the restriction is relaxed, making it easier for the drug at the front of the jam to move forward. A slight movement of the leading drug relieves the pressure on the following drugs, changing the state of the drug chain, which helps to eliminate drug congestion. Moreover, this can be easily implemented by slightly additionally operating the regulating mechanism, and since the pressure on the unwanted drugs is relieved, there is no risk of damaging the drug, even if it is fragile. Therefore, according to the present invention, the width-regulating function of the regulating mechanism can be made to be useful for resolving drug congestion in a simple manner to the extent that even fragile drugs are not damaged.
[0021] Furthermore, in the drug feeder of the present invention (Solution 7), the width of the drug transport path is reduced, in other words, the width of the drug transport path is expanded in a stepwise manner rather than continuously. This allows the restricted drugs to move laterally intermittently, which reduces friction between the drugs during movement and reduces the pushing against each other of the drugs. The drugs are aligned in order between movements, which reduces the impact on the drugs and naturally and efficiently eliminates drug congestion. [Brief description of the drawings]
[0022] [Figure 1] FIG. 1 shows an overall structure of a drug feeder according to a first embodiment of the present invention, where (a) is an external perspective view and (b) is a vertical sectional front view. [Diagram 2] 3A and 3B show the structure of an inclined rotor of a medicine feeder, in which FIG. 3A is an overall external perspective view, and FIG. 3B is a three-view diagram of a disk part of the inclined rotor. [Diagram 3] 1A and 1B show the structure of an annular rotor of a medicine feeder, in which (a) is an overall longitudinal sectional view, (b) is an enlarged view of a part thereof, and (c) is a longitudinal sectional view showing an inclined state. [Figure 4] 1A is a plan view of the upper peripheral edge of the annular rotor, and FIG. [Diagram 5] The figures show the structure of the sorting mechanism and regulating mechanism of the drug feeder, where (a) is an external oblique view of the sorting mechanism sorting the drugs, and (b) is an external oblique view showing the sorting situation by the oblique abutment surface of the middle stage operating part of the sorting mechanism. [Figure 6] The structure of the regulating mechanism of the drug feeder and the general configuration of the control unit are shown, where (a) is a plan view of the regulating mechanism when a drug is placed in the mold storage area, (b) is a plan view and an end view of the first regulating member, and (c) is a functional block diagram of the control unit. [Figure 7] 13 is a flowchart showing approximately half of a medicine discharge operation control function. [Figure 8] 13 is a flowchart showing the remaining part of the medicine discharge operation control function. [Figure 9] 1A and 1B show the state immediately after medicines have been added to the medicine feeder, with (a) being a plan view and (b) being a longitudinal sectional front view. [Figure 10] 13A and 13B show an operating state in which the medicines are properly aligned and discharged in sequence, with (a) being a plan view and (b) being a longitudinal sectional front view. [Figure 11] 13A and 13B show an operating state in which the drug is jammed at the regulating member, where (a) is a plan view and (b) is a longitudinal front view. [Figure 12] 13A and 13B show an operating state in which the drug congestion has been eliminated by widening the drug transport path, where (a) is a plan view and (b) is a longitudinal front view. [Figure 13] 13 shows an operating state where only one medicine remains unextracted, (a) being a plan view and (b) being a longitudinal front view. FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0023] A specific embodiment for carrying out such a drug feeder of the present invention will be described in the following Example 1. The first embodiment shown in Figs. 1 to 13 embodies all of the above-mentioned solutions 1 to 7 (claims 1 to 7 as originally filed). In addition, in order to simplify the illustrations, fasteners such as bolts and electrical circuits such as motor drivers have been omitted, and only those parts necessary for explaining the invention and those related thereto are illustrated. EXAMPLES
[0024] A specific configuration of a drug feeder according to a first embodiment of the present invention will be described with reference to the drawings. Fig. 1 shows the overall structure of a drug feeder 10, where (a) is an external perspective view and (b) is a vertical sectional front view. FIG. 2 shows the structure of the inclined rotor 30, where (a) is an external perspective view and (b) is a three-sided view of the disk portion 30a. Furthermore, Figures 3 and 4 show the structure of the annular rotating body 20, with Figure 3(a) being an overall longitudinal cross-sectional view, Figure 3(b) being an enlarged view of a portion thereof, Figure 3(c) also being an overall longitudinal cross-sectional view, Figure 4(a) being a plan view of the upper peripheral portion 23 of the annular rotating body 20, and Figure 4(b) being an enlarged view of a portion thereof.
[0025] Figure 5 also shows the structures of the sorting mechanism 60 and the regulating mechanism 70, where (a) is an external oblique view of the sorting mechanism 60 sorting the drugs 5, 5, 5b, and 5c, and (b) is an external oblique view showing the sorting situation by the oblique contact surface of the middle-stage acting part 62b of the sorting mechanism 60. 6(a) and (b) show the structure of the restriction mechanism 70, where (a) is a plan view showing the main parts of the restriction mechanism 70 in a simplified manner, and (b) is a plan view and an end view of a first restriction member 71. FIG. 6(c) is a functional block diagram of the controller 80 (controller), and FIGS. 7 and 8 are flow charts showing the medicine discharge operation control function of the controller 80. As shown in FIG.
[0026] The drug feeder 10 (see FIG. 1) is of a double rotation type and comprises a housing, a peripheral wall 11 located at the top of the housing, the central portion of which is hollowed out in an approximately circular shape, an annular rotor 20 installed with its upper end loosely fitted into the inner peripheral wall surface 11a, i.e., the inner peripheral wall surface of the hollow peripheral wall 11, or installed directly below the hollow peripheral wall 11, an inclined rotor 30 installed within the hollow of the annular rotor 20, a bearing mechanism 40 that supports the outer annular rotor 20 so that it can rotate about its axis, a rotation drive mechanism 50 that drives the rotation of these mechanisms, a sorting mechanism 60 and a regulating mechanism 70 that are provided on the upper side of the peripheral wall 11 and have their operating parts positioned inside the inner peripheral wall surface 11a, a drug drop detection means 56 consisting of a photosensor or the like that detects drugs carried by the annular rotor 20 to the drop discharge port 14 and dropped therefrom, and a controller 80 (control unit) that controls the rotation of the annular rotor 20 and the inclined rotor 30.
[0027] Before providing a detailed description of each of these components, we will first explain the general configuration and main functions of the main components so that the division of roles and other aspects can be easily understood. The annular rotating body 20 is supported by a support mechanism 40 and is maintained in a state in which it can rotate about a vertical line or a vertical line slightly inclined therefrom. The inclined rotor 30 is mounted inside the annular rotor 20 and is maintained in a state in which it can rotate about an axis that is inclined from the vertical line by a larger amount than the above-mentioned vertical line. The inclined rotor 30 closes the hollow space of the annular rotor 20 at a lower portion, and the combination of the two rotors 20, 30 forms a rotating vessel 20+30 with an open top.
[0028] Furthermore, when the inclined rotor 30 rotates about its axis, it carries up the solid drug on the inclined surface and sends it onto the upper peripheral portion 23 of the annular rotor 20, and when the annular rotor 20 rotates in the forward direction (when rotating in the forward direction), the circular motion of the upper peripheral portion 23 transports the drug toward the drop discharge port 14. The sorting mechanism 60 is designed to softly come into contact with the medicine transported by the circular rotation of the upper end peripheral portion 23 of the annular rotor 20, thereby breaking up overlapping and clumping of the medicine within a reasonable range. The regulating mechanism 70 aligns the medicines transported by the circulatory rotation of the upper peripheral portion 23 of the annular rotor 20 in a single vertical row and a single horizontal row.
[0029] The rotation drive mechanism 50 is provided with a rotation drive motor 54a for rotating the inclined rotor 30 and a rotation drive motor 54b for rotating the annular rotor 20, and the annular rotor 20 and the inclined rotor 30 can be rotated individually by independent driving of the motors 54a and 54b. For example, stepping motors are used for both motors 54a and 54b, and their synchronization and cooperation are left to the control of a controller 80. The controller 80 (control unit) is mainly based on a programmable microprocessor, and inputs the output of the drug drop detection means 56. In addition to controlling the rotation drive motors 54a, 54b of the rotation drive mechanism 50, it also controls the lift drive motor 60a of the sorting mechanism 60 and the advance / retract drive motor 70a of the regulating mechanism 70 (see Figures 1(a) and 6(c)).
[0030] A specific description of each of these various components will now be provided. First, in the peripheral wall 11 (see Fig. 1, Fig. 13, and Patent Documents 2 to 5), a drop discharge port 14 is formed vertically penetrating the peripheral wall 11 at a portion corresponding to the tip of the above-mentioned central hollow and the inner peripheral wall surface 11a extending obliquely toward the outer periphery, and a drug drop detection means 56 is provided facing the drug drop path extending downward from the drop discharge port 14. Also (see Fig. 13), a discharge guide 13 is formed in the hollow of the peripheral wall 11, protruding obliquely toward the center, in order to send the drug on the upper end peripheral portion 23 of the annular rotor 20 to the drop discharge port 14 by the rotation of the annular rotor 20. Furthermore, a conveying surface guide 12 is formed at the tip of the discharge guide 13, which extends downward from the tip and also forward to become the most advanced end, so as to prevent the drug from undesirably falling toward the inclined rotor 30 in reaction to contacting the discharge guide 13.
[0031] The inclined rotor 30 (see FIG. 2 and Patent Documents 2 to 5) is mainly composed of a roughly disk-shaped disk portion 30a, and an axial center portion 31 is inserted into the center of the disk portion 30a and protrudes up and down. The disk portion 30a has a roughly flat upper surface in its central portion 32, but the peripheral portion 33 has a delivery portion 34 and a push portion 35 alternately formed in the circumferential direction so that the drug can be efficiently pushed up and delivered to the annular rotor 20 even at a low speed. The delivery portion 34 shown in the figure is a locally chamfered outer downward cutout larger than the drug, and the push portion 35 is a rising portion located at the rear end side of both ends in the circumferential direction of such a delivery portion 34. In addition, parallel wavy unevenness is formed everywhere on the upper surface of the disk portion 30a by carving a large number of thin, shallow linear grooves extending roughly in the radial direction in order to promote the rolling of the drug on the inclined surface.
[0032] The annular rotor 20 (see FIG. 3 and Patent Documents 2 to 5) has an overall shape like a bowl with the bottom removed, with the outer periphery consisting of a cylindrical lower part 21 and a brim-shaped upper part 22, and the inner periphery has a hollow diameter that is greatest at the uppermost position, the upper end peripheral part 23, and the hollow diameter becomes smaller the further down from there. Therefore, the inclined rotor 30 can be freely inserted and removed from the hollow of the annular rotor 20, making assembly and part replacement easy. On the upper surface (drug transport path) of the upper end peripheral portion 23 of the upper portion 22 of such an annular rotating body 20 (see Figures 3 and 4), a number of grooves 23a and engravings 23b are provided in a circumferential row at equal pitch to prevent and suppress rolling of drugs that tend to roll, and a chamfer 23c with an inclination angle α is formed around the entire circumference of the outer circumferential portion of the upper end peripheral portion 23.
[0033] Furthermore, (see FIG. 3(c)), the vertical line (two-dot chain line in the figure) corresponding to the central axis of rotation of the upper portion 22 and thus the annular rotor 20 is inclined at an angle β from the vertical line (one-dot chain line in the figure). This inclination angle β, which is highlighted in the figure, is suppressed to, for example, about 3.5° so as not to impair the drug delivery function, and is smaller than the inclination angle α of the chamfer 23c of the upper peripheral portion 23 described above. Therefore, even if the inclination of the chamfer 23c of the upper peripheral portion 23 from the horizontal changes between the maximum inclination (α+β) when descending (to the left in the figure) and the minimum inclination (α-β) when ascending (to the right in the figure) as the upper peripheral portion 23 rotates, the chamfer 23c of the upper peripheral portion 23 is always maintained in a state of being lowered toward the outer periphery. Note that compared with the inclination of the central axis of rotation of such an annular rotor 20, the inclination of the central axis of rotation of the inclined rotor 30 described above is several times larger.
[0034] The sorting mechanism 60 (see Figures 1, 5 and Patent Document 5) comprises a support part 61 with two arms, one long and one short, extending horizontally, and three vertically elongated sorting members whose upper ends are held by the support part 61 and whose lower action parts 62a, 62b, 62c are positioned above the upper peripheral edge 23 of the annular rotor 20. By the lifting drive motor 60a raising and lowering the support part 61 under the control of the controller 80, the vertical distance between the lower ends of the action parts 62a, 62b, 62c of the three sorting members and the drug transport path of the upper peripheral edge 23 of the annular rotor 20 can be expanded or contracted.
[0035] In the example shown in FIG. 5, the action member (62a) that hangs down from the short arm of the support part 61 and acts first on the medicine on the medicine transport path is made of a small bead-like member such as a ball chain. The action member (62c) that hangs down from the tip of the long arm of the support part 61 and acts last on the medicine on the medicine transport path is made of a larger bead-like member. The action member (62b) that hangs down from a position slightly closer to the base from the tip of the long arm of the support part 61 and acts on the medicine midway on the medicine transport path is made of a plate-like body with its upper end loosely held by a loose fit. In both cases, the free lower end acts while escaping from the abutting medicine, so that the overlapping of tablets is broken up to the extent that it does not impact the medicine.
[0036] The regulating mechanism 70 (see Figures 1, 5(a), 6(a), and Patent Document 5) comprises a first regulating member 71 and a second regulating member 72 whose rear oscillating ends are positioned directly above the drug transport path of the upper peripheral portion 23 of the annular rotating body 20, thereby narrowing the width of the drug transport path from the outer periphery, a link mechanism 73 connected to both members 71, 72 via a pin-shaped rotation-permitting shaft member or the like, and a mold storage area 74 capable of containing a sample drug 5. The swing end of the first restricting member 71 is located between the action parts 62a, 62b of the sorting mechanism 60, and the swing end of the second restricting member 72 is located behind the action part 62c of the sorting mechanism 60, i.e., near the drop discharge port 14. Both restricting members 71, 72 swing simultaneously and in the same manner in response to the longitudinal advancement and retreat of the link mechanism 73, so that the expansion and contraction states of the medicine transport path width by both restricting members 71, 72 are linked.
[0037] When drug 5 is placed in the mold storage area 74, drug measurements can be taken to measure the dimensions of drug 5 such as its length, width and thickness, and when no drug is placed in the mold storage area 74, the drug transport path width can be expanded or contracted by freely pushing and pulling one end of the link mechanism 73 to swing the ends of the regulating members 71, 72 without being restricted by this. Drug measurement is performed by the controller 80 acquiring the distance traveled when the forward / backward drive motor 70a advances and retreats the movable member (drug clamping member) of the mold storage area 74 under the control of the controller 80 to clamp the drug measurement area. The width of the drug transport path is expanded or contracted when the forward / backward drive motor 70a advances or retreats the movable member of the mold storage area 74 under the control of the controller 80, causing the link mechanism 73 to advance or retreat in response and causing the first regulating members 71, 72 to swing.
[0038] The first and second restricting members 71 and 72 have the same shape, so to explain the first restricting member 71 (see FIG. 6(b), Patent Document 5), the swing center of the first restricting member 71 at the left end in the figure is located on the peripheral wall 11 side, and the swing end of the first restricting member 71 at the right end in the figure is located above the upper peripheral edge 23 of the annular rotating body 20. The inner peripheral side of the first restricting member 71 is formed with a lower stage portion 71a that performs a width restriction function and an upper stage portion 71b that protrudes further inward, and an inclined surface is formed between the lower stage portion 71a and the upper stage portion 71b. Therefore, in the first restricting member 71a, in addition to the lower stage portion 71a performing a strict width restriction function according to the advancement and retreat of the link mechanism 73, the upper stage portion 71b performs a height restriction that reliably breaks down the overlapped medicines. The second restricting member 72 is the same.
[0039] When the controller 80 (see Figures 1(a), 6(c), and Patent Documents 2 to 5) receives an initialization instruction via manual operation, a control signal, etc., it performs initialization to clear various data values such as the number of drugs dispensed, and sets each of the motors 54a, 54b, 60a, 70a, etc. to their initial states. In addition, when an instruction to measure the drug is received (Figure 6(a), see Patent Document 5), the forward / backward drive motor 70a is driven to measure the width and thickness of the drug 5 in the mold storage area 74, and the data is acquired and stored, and even transferred to a higher-level device.
[0040] Furthermore, when the controller 80 (see FIG. 6(c), Patent Document 5) receives a drug discharge command, if the controller 80 holds dimensional data including width and thickness data related to the target drug, it immediately performs drive control of the regulating mechanism 70 by operating the lifting drive motor 60a and the forward / backward drive motor 70a based on the dimensional data, or if the controller 80 does not hold dimensional data including width and thickness data related to the target drug, it performs drive control of the regulating mechanism 70 by operating the lifting drive motor 60a and the forward / backward drive motor 70a based on the dimensional data. The controller 80 then adjusts the regulating amount, such as the height from the drug transport path to the action parts 62a, 62b, and 62c of the sorting mechanism 60 and the width of the drug transport path narrowed by the tips of the regulating members 71 and 72 of the regulating mechanism 70, to suit the target drug.
[0041] Then, the controller 80 rotates the rotary drive motors 54a and 54b to control the drug discharge operation, while monitoring the output of the drug drop detection means 56 to grasp the discharge of each drug, and counts them to obtain a count of the amount of drug discharged. In addition, the system also performs drug count management, such as stopping drug discharge operation control when the acquired count value of the discharged drugs reaches a specified number (a specified prescribed amount, such as the prescribed amount for one patient).
[0042] Such drug discharge operation control will be described in detail (see the flowcharts of Figs. 7 and 8). First, in the initial state immediately after the drug is placed on the inclined rotor 30, the annular rotor 20 and the inclined rotor 30 are temporarily rotated in the forward direction (rotation in the forward direction) at high speed for a predetermined period of time in order to quickly send the drug from the inclined rotor 30 onto the annular rotor 20 (step S11), and then both rotors 20, 30 are continuously rotated in the forward direction at a constant speed in order to stabilize the drug transport (step S12).
[0043] Then, based on the output of the chemical agent dropping detection means 56, it is examined whether or not a chemical agent is discharged (step S13). When a chemical agent discharge is detected (Y in step S13), the number of discharged agents is counted up and the value of the undetected time t is cleared to zero (step S14). Then, it is examined whether or not the discharge of the specified number of chemical agents has been completed by the chemical agent discharge at that time (step S15). When it is determined that the discharge of the specified number has been completed (Y in step S15), for preventing excessive discharge, the rotations of both rotators 20 and 30 are quickly decelerated, further reversed, and then stopped (step S23), and the control of the discharge of the specified number of chemical agents is terminated.
[0044] On the other hand, when the discharge of the specified number of chemical agents has not been completed yet (N in step S15), although the illustration in the flowchart is omitted, if the controller 80 has controlled the forward and backward drive motor 70a to expand the width of the chemical agent conveyance path until then, the forward and backward drive motor 70a is controlled to reduce the width of the chemical agent conveyance path and return it to the state before the expansion. And while the undetected time t elapsed from the most recent chemical agent discharge is less than the predetermined time t1 [0 ≦ t < t1] (normal time interval) (Y in step S16), as it is, the process is repeated from the chemical agent discharge detection (step S13).
[0045] Also, while the undetected time t is within the predetermined time [t1 ≦ t < t2] (stagnation time interval), as a measure for resolving stagnation considering the possibility that chemical agent stagnation has occurred at the regulation members 71 and 72, the forward and backward drive motor 70a is controlled to gradually expand the width of the chemical agent conveyance path at the upper peripheral edge portion 23 of the annular rotator 20 (N in step S16, step S17, Y in step S18). Thereby, when the chemical agent detection interval (undetected time t) at the chemical agent dropping detection means 56 reaches the stagnation time interval which is a set value larger than the normal time interval (predetermined time t1), the chemical agent feeder 10 controls the regulation members 71 and 72 to expand the width of the chemical agent conveyance path. Note that the expansion of the width of the chemical agent conveyance path may be smoothly expanded little by little, but it is performed stepwise such as in steps expecting the effect of shaking.
[0046] Furthermore, when the undetected time t is within a predetermined time [t2 ≤ t < t3], considering the possibility that some drugs may aggregate and form lumps on the inclined rotating body 30, etc., and also expecting the effect of breaking up the lumps, the inclined rotating body 30 is reversely rotated (rotated on the backward side) (N in step S18, step S19, Y in step S20). In addition, when the undetected time t is within a predetermined time [t3 ≤ t < t4], considering the possibility that the drugs on the inclined rotating body 30 are becoming less remaining, etc., in order to quickly convey the remaining drugs, both rotating bodies 20 and 30 are rotated forward at high speed (N in step S20, step S21, Y in step S22).
[0047] Also, after that (t4 - t10, remaining drug residence time interval), considering the possibility that the slightly remaining drugs may stay due to undesired adhesion or snagging, etc., a more elaborate discharging operation is carried out (steps S30 - S40 in FIG. 8). Specifically, when the undetected time t is within a predetermined time [t4 ≤ t < t5], both rotating bodies 20 and 30 are continuously rotated forward at a constant speed (N in step S22, step S30, Y in step S31).
[0048] Then, when the undetected time t is within a predetermined time [t5 ≤ t < t6], considering the possibility that drugs may stay at the boundary between the upper peripheral edge portion 23 of the annular rotating body 20 and the discharge guide 13 or the conveyance surface guide 12, etc., the annular rotating body 20 is gently reversely rotated (N in step S31, step S32, Y in step S33), and when the subsequent undetected time t is within a predetermined time [t6 ≤ t < t7], the inclined rotating body 30 is gently reversely rotated (N in step S33, step S34, Y in step S35).
[0049] Thereafter, while the inclination rotator 30 is being vibrated, it is gently rotated forward when the undetected time t is within the predetermined time [t7 ≤ t < t8] (N in step S35, step S36, Y in step S37). This vibratory rotational movement of the inclination rotator 30 is achieved by the controller 80 repeating control to cause the rotation drive motor 54b to perform a small forward rotation corresponding to the vibration and then a smaller backward rotation than that, so that it can be executed even without the addition of a vibration motor or the like.
[0050] Furthermore, thereafter, in order to promptly deliver any drug that has become movable due to the vibration effect, when the undetected time t is within the predetermined time [t8 ≤ t < t9], a start-up reverse rotation control is performed to rotate the inclination rotator 30 at high speed in the reverse direction (N in step S37, step S38, Y in step S39), and then, when the undetected time t is within the predetermined time [t9 ≤ t < t10], a start-up forward rotation control is performed to rotate the inclination rotator 30 at high speed in the forward direction (N in step S39, step S40, Y in step S41). Note that the above start-up reverse rotation control is a rough guide of about one rotation, but it can be more or less. Also, the subsequent start-up forward rotation control is the final delivery operation, so about several rotations are desirable, but it can be more or less.
[0051] Then, as a result of waiting for the drug detection by the drug drop detection means 56 while performing the above drug discharge operation control, when the undetected time t reaches the predetermined time [t10] without detecting drug discharge (N in step S41), it is determined that the time has expired and the stored drug has run out, and the controller 80 stops the rotation of both rotators 20 and 30 (step S42) and ends the drug discharge control.
[0052] Regarding the drug feeder 10 of the first embodiment as described above, its usage mode and operation will be described with reference to the drawings. In FIGS. 9 to 13, (a) is a plan view and (b) is a longitudinal front view in each case.
[0053] Of these, Figure 9 shows the state immediately after the drug 5 has been dropped onto the inclined rotor 30, Figure 10 shows the operating state when the drug 5 is aligned on the drug transport path at the upper end peripheral portion 23 of the annular rotor 20 and is being smoothly discharged one after another, Figure 11 shows the operating state when the drug 5 becomes jammed at the second regulating member 72, Figure 12 shows the operating state when the regulating mechanism 70 widens the width of the drug transport path thereby eliminating the jam of the drug 5, and Figure 13 shows the operating state when only one drug 5 remains without being discharged.
[0054] Before using drug feeder 10 for dispensing medicine, it is necessary to have controller 80 store at least the width and thickness of the drug shape data. If the data has been entered in advance, this step can be omitted, but if not, data entry or measurements and data setting are required. Regarding the external dimensions of a drug, the relationship is [length ≧ width ≧ thickness]; for a perfect sphere, the relationship is [length = width = thickness], for cylinders and ellipsoids, the relationship is often [length > width = thickness], and for disks and disc-shaped objects, the relationship is often [length = width > thickness].
[0055] Measurements may be taken with a separate device, and the dimensional values may be input to drug feeder 10 by manual operation or by downloading from a higher-level device, but with this drug feeder 10, when drug 5 is placed sideways in mold storage area 74 (see FIG. 6(a)) and operated in width measurement mode, controller 80 operates forward / backward drive motor 70a to automatically measure the width of the drug and set the data. When drug 5 is placed vertically in mold storage area 74 and operated in thickness measurement mode, similarly, measurements related to the thickness of the drug are automatically taken and data set. Thereafter, drug 5 can be taken out of mold storage area 74 and placed in rotating container 20+30 to be included in the dispensing target (see FIG. 9).
[0056] When the drug feeder 10 is operated in the preparation mode, the controller 80 operates the motor 60a of the sorting mechanism 60 based on the drug thickness data, and the support part 61 of the sorting mechanism 60 rises and falls accordingly, thereby adjusting the height of the action parts 62a, 62b, 62c to match the drug thickness (see Figs. 5 and 9(b)). The controller 80 operates the motor 70a of the regulating mechanism 70 based on the drug width data, and the link mechanism 73 of the regulating mechanism 70 moves longitudinally via the mold storage space 74 accordingly, thereby swinging the regulating members 71 and 72, thereby adjusting the width of the corresponding part of the drug transport path above the upper peripheral part 23 of the annular rotor 20 to match the width of the drug (see Figs. 5(a) and 9(a)).
[0057] Then, the number of drugs specified in the drug prescription and other initial values are set as data in the controller 80, and the number of drugs 5, or more than that number, is fed into the drug feeder 10. Specifically, the drugs are fed onto the inclined rotor 30 surrounded by the annular rotor 20 (see FIG. 9). Thereafter, when drug feeder 10 is operated in the automatic dispensing mode, both rotors 20, 30 temporarily rotate at high speed in the forward direction (see FIG. 7S11), and the drugs are quickly transferred from inclined rotor 30 to annular rotor 20. Then (see FIG. 7S12), when the drugs start to line up in the drug transport path at upper end peripheral portion 23 of annular rotor 20, the rotational speeds of both rotors 20, 30 are reduced to a predetermined constant speed suitable for stable transport, and both rotors 20, 30 continue to rotate in the forward direction.
[0058] As both rotors 20, 30 continue to rotate forward at a constant speed, the drugs 5 are successively lifted by the inclined rotor 30 and transferred onto the upper peripheral portion 23 (drug transport path) of the annular rotor 20 (see Figure 10), and as the annular rotor 20 rotates, they progress along the drug transport path and attempt to pass under the action portions 62a, 62b, 62c of the sorting mechanism 60 in succession. At that time, for the drugs 5b, 5c stacked one on top of the other, the upper drug 5b comes into contact with the action parts 62a, 62b, 62c at the lower end of the sorting mechanism 60 (see Figure 5(b)), and the reaction force often breaks the stack; however, since the sorting mechanism 60 moves away when the action part is pushed sideways, the drug 5 is not damaged, but the stack may remain intact.
[0059] However, only a small number of overlapping medicines pass through the sorting mechanism 60 while remaining overlapped, and as they proceed along the medicine transport path with the rotation of the annular rotor 20, the upper medicines are pushed by the upper stage portions 71b of the restricting members 71, 72 due to interference with the first restricting member 71 and the second restricting member 72, and are dropped from above the lower medicines onto the upper end peripheral portion 23 of the annular rotor 20 or onto the inclined rotor 30. In contrast, the bottom medicine is released from the overlapping state and does not interfere even indirectly with the upper stage portions 71b of the restricting members 71, 72, so it slips past the lower stage portion 71a and is carried to the drop discharge port 14 (see FIG. 10).
[0060] Each time the discharge of the medicine is detected (see FIG. 7S13Y), the value of the non-detection time t is cleared to zero (see FIG. 7S14). Although not shown, the rotation of both rotors 20, 30 is returned to a constant forward rotation speed, and if the width of the medicine transport path has been expanded, it is returned to its original width. Furthermore, the number of discharged medicines is counted up, and it is confirmed whether the number of discharged medicines has reached a designated number (see FIG. 7S15). When the number of medicines discharged reaches the specified number (see Figure 7S23), the rotation of both rotating bodies 20, 30 is quickly decelerated and then slightly reversed before being stopped in order to prevent excessive discharge due to inertia, thereby completing the operation of discharging the specified number of medicines.
[0061] In contrast, when the number of discharged medicines has not yet reached the specified number (see FIG. 7S15N), the following discharge operation is attempted (see FIG. 7S16 to FIG. 8S42) while waiting for detection of the next discharge of medicine (see FIG. 7S13N). Specifically, until the undetected time t reaches the time t1, both rotators 20 and 30 are rotated forward at a constant speed (see Fig. 7S16Y). However, when the drug is not discharged even after the time t1 has elapsed (see Fig. 7S16N), as a countermeasure when the drug is stagnant on the drug conveyance path at the upper peripheral edge 23 of the annular rotator 20, the regulating members 71 and 72 sometimes swing, and the lateral width of the drug conveyance path is intermittently enlarged (see Fig. 7S17). When the drug was stagnant on the drug conveyance path (see Fig. 11), the stagnation is thereby resolved (see Fig. 12).
[0062] Even so, when the undetected time t reaches the time t2 without the drug being discharged, as a countermeasure when the drug is aggregated on the inclined rotator 30, the inclined rotator 30 is rotated reversely to break up the mass (see Fig. 7S19). Furthermore, when the undetected time t reaches the time t3 without the drug being discharged, as a countermeasure when the remaining drug on the inclined rotator 30 has decreased, both rotators 20 and 30 are rotated forward at high speed (see Fig. 7S21).
[0063] Even so, when the undetected time t reaches the time t4 without the drug being discharged, as a countermeasure when the remaining drug, which has become small, stays due to undesired adhesion, snagging, etc., a more elaborate discharging operation is carried out (see steps S30 to S40 in Fig. 8). Specifically, both rotators 20 and 30 are continuously rotated forward at a constant speed while the undetected time t is within the predetermined time [t4 ≤ t < t5] (see Fig. 8S31). While the undetected time t is within the predetermined time [t5 ≤ t < t6], as a countermeasure when the drug stays at the boundary between the upper peripheral edge 23 of the annular rotator 20 and the discharge guide 13 or the conveyance surface guide 12, the annular rotator 20 is gently rotated reversely (see Fig. 8S32).
[0064] Even so, when the undetected time t reaches the time t6 without the drug being discharged, the inclined rotator 30 is gently rotated reversely (see Fig. 8S34). While the undetected time t is within the predetermined time [t7 ≤ t < t8], the inclined rotator 30 is gently rotated forward with vibration (see Fig. 8S36). This type of rotational motion accompanied by vibration effectively eliminates or suppresses adhesion forces, etc. of residual drug on the inclined rotor 30 (see Figure 13), thereby accurately preventing the occurrence or continuation of undesirable drug residue on the inclined rotor 30.
[0065] Furthermore, the vibration of the inclined rotor 30 does not disappear there alone, but is transmitted to other components such as the annular rotor 20 that come into contact with the drug, so that the occurrence or continuation of undesirable drug residue on the annular rotor 20, etc. can be avoided or suppressed. Thereafter, when the undetected time t reaches time t8, which is the time when the adhesive force of the residual medicine is expected to be sufficiently dissolved, the inclined rotor 30 is rotated in the reverse direction at high speed by the swing-reverse control (see FIG. 8S38), and when the undetected time t reaches time t9, the inclined rotor 30 is rotated in the forward direction at high speed by the swing-forward control (see FIG. 8S40). Therefore, when the residual medicine is on the inclined rotor 30, it is quickly transferred to the medicine transport path at the upper end peripheral portion 23 of the annular rotor 20 and sent to the drop discharge port 14.
[0066] When all of these attempts have been made without the drug being discharged and the undetected time t reaches time t10, it is certain that the rotating container 20+30 has become empty, so the controller 80 determines that the time has expired, stops the rotation of both rotating bodies 20, 30 (see FIG. 8S42), and ends the drug discharge process. All that's left to do is wait for manual refills of medication, etc.
[0067] [others] In the above embodiment, the expansion of the lateral width of the drug transport path at the upper end peripheral portion 23 of the annular rotor 20 is performed first, and then the vibration rotation control of the inclined rotor 30 is performed. However, for other methods related to the rotation control of the annular rotor 20 or the inclined rotor 30, such as switching the rotation direction or changing the rotation speed, the execution order or execution time may be changed as appropriate. [Industrial Applicability]
[0068] The drug feeder of the present invention may be used to replace some or all of the many rotary alignment type drug feeders installed in a tablet packaging machine, or may be installed in a tablet divider which has only one or a small number of drug feeders, and may even be installed in a tablet counter (drug counter) which counts the number of drugs sequentially dispensed in a device which fills medicine bottles with tablets or other medicines. [Explanation of symbols]
[0069] 5,5a,5b,5c drugs, 10...medicine feeder, 11...peripheral wall, 11a...inner peripheral wall surface (hollow inner wall surface of the peripheral wall), 12... conveying surface guide, 13... discharge guide, 14... drop discharge port, 20... annular rotating body, 21... lower part, 22... upper part, 23... upper end peripheral portion (drug delivery path), 23a... groove, 23b... engraving, 23c... chamfering, 30... inclined rotor, 30a... disk portion, 31...Axis center part, 32...Center part, 33...Peripheral part, 34...Delivery part, 35...Pushing part, 20+30...rotating container, 40...support mechanism, 50...rotation drive mechanism, 54a, 54b...rotation drive motors, 56...medicine drop detection means, 60...sorting mechanism, 60a...lifting drive motor, 61: Support portion; 62a, 62b, 62c: Working portion (drug contact portion); 70: Restriction mechanism, 70a: Advance / retreat drive motor, 71: first restricting member; 71a: lower portion; 71b: upper portion; 72: second restriction member; 73: link mechanism; 74: mold storage area (measuring mechanism); 80...Controller (control unit)
Claims
1. a control unit which controls the rotation of the annular rotor and the rotation of the inclined rotor; and a drug drop detection means which detects drugs that have been carried to a drop discharge port by the annular rotor and dropped, wherein the control unit performs the rotation control while waiting for drug detection by the drug drop detection means, and determines that the contained drugs have run out when a predetermined time has elapsed. The drug feeder is characterized in that the inclined rotor can rotate both forward and reverse around the inclined line, and the control unit performs vibration rotation control to rotate the inclined rotor while vibrating it, by controlling the inclined rotor to alternately rotate small forward rotations corresponding to vibrations and reverse rotations smaller than the forward rotations prior to the time-out.
2. A drug feeder as described in claim 1, characterized in that the control unit is configured to perform a swing reversal control for rotating the inclined rotor in the reverse direction at high speed after executing the vibration rotation control.
3. A drug feeder as described in claim 2, characterized in that the control unit is configured to perform forward swing control to rotate the inclined rotor in a forward direction at high speed after executing the reverse swing control.
4. A drug feeder as described in any of claims 1 to 3, characterized in that the regulating mechanism regulates the lateral width of the drug transport path above the upper peripheral portion of the annular rotor, and the amount of regulating the lateral width is increased or decreased according to the control of the control unit, and the control unit controls the regulating mechanism to expand the lateral width when the drug detection interval by the drug drop detection means reaches a set value of a congestion interval which is larger than a normal interval prior to executing the vibration rotation control.
5. A drug feeder as described in claim 4, characterized in that when the drug fall detection means detects drug fall after the control unit controls the regulating mechanism to expand the width, the control unit accordingly controls the regulating mechanism to return the width to its state before expansion.
6. A drug feeder as described in claim 4 or claim 5, characterized in that the control unit is configured to increase the width in stages.
Citation Information
Patent Citations
Drug delivery device
JP2017164560A
Medicine feeder
JP2018108277A
Medicine delivery device
JP2020025620A
Medicine Feeder
JP6736074B1
Medicine Feeder
JP6736075B1
